Article: INDIA'S STRIDES ARCOLAB SIGNS AGREEMENT WITH CLINTON FOUNDATION.

MUMBAI, Jan 16 Asia Pulse - Strides Arcolab Ltd (NSI:STAR) has signed an agreement with the Clinton Foundation in order to make available a range of affordable anti-retroviral drugs for treating AIDS.

The anti-retroviral drugs would be made available in countries that are under the aegis of the Clinton Foundation HIV / AIDS initiative, the company informed the Bombay Stock Exchange.

"We are committed to supply a comprehensive range of first line and second line anti-retroviral drugs that meet global quality standards at affordable prices, " Strides Arcolab Group CEO and managing director, Arun Kumar, said at a ceremony in New York.

Speaking on ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!